$HCM news
The latest HCM stock news: headlines, filings, AI summaries and sentiment for $HCM, updated around the clock.
- HUTCHMED Announces Major Licensing Agreement with GSK for Experimental Cancer Therapy
- HUTCHMED Enters $1.3B Deal With GSK for Ex-China Rights to Preclinical Cancer Therapy HMPL-A830
- HutchMed Enters Licensing Deal with GSK for Cancer Therapy, Could Generate Up to $1.295 Billion
- AstraZeneca and Hutchmed Report Positive Results from Lung Cancer Trial
- HUTCHMED Reports Strong First-Half Earnings and Maintains Full-Year Guidance
- HUTCHMED Gains Attention Amid China Biotech Re-Rating